Skip Ribbon Commands
Skip to main content
Sign In
Skip to main content Open accessibility information page

Press Release

​​​​​​​​​​​​​​For Immediate Release:
May 6, 2020

Office of The Attorney General
Gurbir S. Grewal, Attorney General

Division of Consumer Affairs
Paul R. Rodríguez, Acting Director
​​​​ For Further Information Contact:
Lisa Coryell 609-292-4791

Proposed Regulation – State Board of Medical ExaminersP

​ ​​​

NEWARK – To address the ongoing opioid overdose epidemic and further increase the public availability of naloxone, the State Board of Medical Examiners (“the Board”) proposes to amend N.J.A.C. 13:35-7.6 to require prescribers to co-prescribe an opioid antidote (for example, naloxone) under certain circumstances.

In addition, the Board proposes to amend N.J.A.C. 13:35-7.6 to implement P.L. 2017, c. 341 to clarify the timing of the requirement to enter into a pain management agreement, amend the definition of “initial prescription,” and revise the definition of “chronic pain” in the rule consistent with the amended statute.  

The proposed regulation, and information on how to submit a comment by June 5, 2020, can be viewed on the Division of Consumer Affairs website


Last Modified: 5/7/2020 6:12 AM